NFKB1 and type 2 diabetes mellitus: Obese type 2 diabetes patients develop visceral obesity with insulin resistance mainly because of inflammatory cytokine production by activation of c-jun N-terminal kinase (JNK) and nuclear factor-kappa B (NF-κB).